Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CLASS I, CLASS II 510(k) CLEARANCE NO LONGER LINKED TO GMP COMPLIANCE; FDA SHIFTING RESPONSIBILITY FOR GMP CONFORMANCE TO DEVICE MANUFACTURERS

This article was originally published in The Gray Sheet

Executive Summary

FDA is eliminating its pre-510(k) clearance good manufacturing practice check for Class I and Class II devices and is shifting responsibility for determining GMP compliance to manufacturers. On March 17, FDA Center for Devices and Radiological Health Director Bruce Burlington issued a memo to staff indicating that the agency is stopping its practice of checking to see if a company is in compliance with GMPs before clearing 510(k)s for Class I and Class II devices. The policy went into effect immediately.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007775

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel